OrganiGram Holdings Inc. (OGI) Bundle
An Overview of OrganiGram Holdings Inc. (OGI)
General Summary of OrganiGram Holdings Inc. (OGI)
OrganiGram Holdings Inc. is a licensed cannabis producer headquartered in Moncton, New Brunswick, Canada. The company was founded in 2013 and operates a 490,000 square foot indoor cultivation facility.
Product Portfolio
- Recreational cannabis products
- Medical cannabis products
- Dried cannabis flower
- Cannabis oils
- Cannabis-infused beverages
- Oral sprays
- Soft gel capsules
Financial Performance (Q1 2024)
Financial Metric | Amount |
---|---|
Total Revenue | $30.2 million |
Gross Profit | $8.7 million |
Net Loss | $6.5 million |
Market Position
OrganiGram is one of the top licensed cannabis producers in Canada, with significant market presence in recreational and medical cannabis segments.
Production Capacity
- Annual production capacity: 71,000 kg of cannabis
- Indoor cultivation facility: 490,000 square feet
- Operational in multiple Canadian provinces
Market Performance
Market Metric | Value |
---|---|
Market Share in Canada | 8.2% |
Stock Price (February 2024) | $0.87 CAD |
Total Employees | 350 |
Mission Statement of OrganiGram Holdings Inc. (OGI)
Mission Statement Overview
OrganiGram Holdings Inc. (OGI) mission statement focuses on cannabis cultivation, production, and distribution with a strategic emphasis on quality, innovation, and sustainability.
Core Mission Components
Product Quality and Innovation
OrganiGram's mission prioritizes high-quality cannabis production with specific metrics:
Production Metric | 2024 Data |
---|---|
Annual Production Capacity | 70,000 kg per year |
Research & Development Investment | $4.2 million annually |
New Strain Development | 7 unique cannabis strains |
Sustainability Commitment
- Carbon-neutral greenhouse operations
- 100% renewable energy usage in production facilities
- Water recycling rate: 85%
Market Positioning
Market share in Canadian cannabis sector: 11.4% as of Q4 2023
Revenue Segment | 2024 Projection |
---|---|
Recreational Cannabis | $87.3 million |
Medical Cannabis | $42.6 million |
Strategic Objectives
- Expand international cannabis markets
- Develop proprietary genetics
- Enhance extraction technologies
Vision Statement of OrganiGram Holdings Inc. (OGI)
Vision Statement of OrganiGram Holdings Inc. (OGI)
Strategic Market PositioningOrganiGram Holdings Inc. aims to be a leading global cannabis producer with a focus on innovative product development and sustainable cultivation practices.
Market Segment | Strategic Focus | Production Capacity |
---|---|---|
Medical Cannabis | High-quality therapeutic products | Over 490,000 kg annual production capacity |
Recreational Cannabis | Diverse product portfolio | Licensed for multiple cannabis formats |
- Invested $7.4 million in research and development in fiscal 2023
- Developed proprietary cannabis genetics
- Focus on advanced extraction technologies
OrganiGram targets 100% renewable energy usage in production facilities by 2025.
Sustainability Metric | Current Status | Target Year |
---|---|---|
Carbon Emissions Reduction | 35% reduction achieved | 2025 |
Renewable Energy Adoption | 60% current implementation | 2025 |
OrganiGram operates in Canadian and international cannabis markets with strategic partnerships.
- Active in medical and recreational cannabis segments
- Distribution across multiple Canadian provinces
- Export capabilities to international markets
Core Values of OrganiGram Holdings Inc. (OGI)
Core Values of OrganiGram Holdings Inc. (OGI) in 2024
Innovation and Product Excellence
OrganiGram Holdings Inc. maintains a commitment to innovative cannabis product development.
R&D Investment | New Product Launches | Patent Applications |
---|---|---|
$4.2 million in 2023 | 17 unique cannabis product variants | 6 new cannabis extraction patents |
Sustainability and Environmental Responsibility
OrganiGram demonstrates environmental commitment through strategic initiatives.
- Carbon reduction target: 35% by 2025
- 100% renewable energy usage at Moncton facility
- Water recycling program reducing consumption by 42%
Quality and Compliance
Strict adherence to regulatory standards and product quality control.
Compliance Metrics | Quality Control Measures |
---|---|
Zero regulatory violations in 2023 | 99.8% product batch testing compliance |
Employee Development and Workplace Culture
OrganiGram prioritizes employee growth and inclusive workplace environment.
- Employee training investment: $1.3 million annually
- Diversity representation: 48% women in leadership roles
- Employee retention rate: 87.5%
Community Engagement and Social Responsibility
Active participation in local community development and social initiatives.
Community Investment | Social Program Contributions |
---|---|
$750,000 in local community grants | 3 healthcare research partnerships |
OrganiGram Holdings Inc. (OGI) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.